Member Info for Livedataaccount

www.accessdata.fda.gov/scripts/opdlisting/oopd/index.cfm

Yesterday avacta was granted orphan drug status by the fda for sickle cell

Search the fda website for approvals done yesterday

Looking for a 1.31 finish

Rippers, I think that's a question we are all asking ourselves. Surely it works or they wouldn't keep upping the dose?

How many did you buy, wyndrum?

Is this a technical pull back?

Last year's results along with an investor presentation were on 30th September last year
So shouldnt be far off until Avacta give an update

Great news!!!

Easyjet do cruises

Looking at a good finish now
140 plus

Americans just waking up now

Bego on the bid

So Avacta are dangling a carrot in front of Takeda?

142

Americans arrived?

Tom the bomb on twitter

Takeda ventures inc have bought a small stake in avacta

https://www.takeda.com/what-we-do/research-and-development/center-for-external-innovation/takeda-ventures/
Takeda Ventures focuses on high-caliber therapeutic and platform based opportunities around the world. We invest in early-stage opportunities that complement Takeda’s pipeline and products.

Our mission is to create strategic growth opportunities for Takeda by investing and nurturing Innovative Life Science Companies in areas aligned with Takeda’s R&D focuses which include; Oncology, Gastroenterology, Neuroscience, and Rare Disease.

Our aim is to access and support therapeutic and platform innovation working closely with academic innovators, entrepreneurs and investors. We invest in seeds or syndicated venture investing providing to the companies access to the resources of a multinational pharmaceutical company.

Bego (jber) seem to be one of the most aggressive market makers that trade avacta along with marex capital. They seem to be the one that drives the price up

Bego in the driving seat.